Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Nanomedicine for Ischemic Cardiomyopathy: Progress, Opportunities, and Challenges provides an historical overview on myocardial infarction and the available clinical and pre-clinical approaches to inhibit correspondence heart failure. Shortcomings of current methods and how nanotechnology can overcome those obstacles in the field is discussed, including the limitations of newly developed cell therapy approaches to clinical translation and how nanoparticles may overcome crucial issues and facilitate the clinical translation of cell therapy. Biomolecular therapy is also explored as another powerful approach for regeneration of heart tissue, including available methods and the systematic delivery of biomolecules using nano-carriers to the injured part of the myocardium through active targeting.
Finally, coverage of major tissue engineering advances for myocardial regeneration, including use of epicardial nano-structured patches for regeneration of injured epicardium and the highly conductive patches for enhancing cross talks between the cardiomyocytes are explored.
This concise, yet rigorous, coverage outlines the innovative and necessary role of nanotechnology in regenerative medicine for cardiac repair, allowing researchers, clinicians and nanotechnologists to examine the strengths and limitations of current findings and predict future trends.
- Introduces concepts of the unique capacities of cardiac-nanotechnology
- Points to potential and promising applications of engineering nanotechnologies on revolutionizing cell therapy and biomolecular therapy approaches for cardiac regeneration
- Bridges the knowledge gap between cardiologists and cardiac regenerative nanomedicine experts
Researchers in biomedical science studying cardiac nanomedicine, cardiologists and nanotechnologists
- Ischemic cardiomyopathy: A Historical Overview
2. Nanotechnology: A Historical Overview
3. Current Clinical Strategies to Prevent Post Myocardial Infarction Heart Failure
3.1. Overview of the Available Approaches
3.2. Challenges with the Current Approach
3.3. Ongoing Clinical Trials
4. Use of Nanoparticulate Systems to Salvage Myocardium
4.1. Nanoparticulate Systems for Monitoring of Therapeutic Cells
4.2. Nanoparticulate Systems for Delivery of Biomolecules and Cells in the Injured Part of Myocardium
4.3. Nanoparticulate Systems for Sustain Delivery of Paracrine Factors
5. Use of Nanoparticulate Systems to Regenerate Myocardium
5.1. Nano-based Scaffolds for myocardial regeneration
5.2. How 3D Printing Approach with Nano-Resolution Can be of Help?
6. Future trends: Clinicians' Point of View
7. Future trends: Nanotechnologists' Point of View
- No. of pages:
- © Academic Press 2020
- 1st June 2020
- Academic Press
- Paperback ISBN:
Dr. Morteza Mahmoudi is an Assistant Professor of Radiology and Precision Health Program at Michigan State University (MSU). Prior coming to MSU, he was an Assistant Professor of Anesthesiology at Brigham and Women’s Hospital, Harvard Medical School. His specific research interest is in nanomedicine and regenerative medicine for the development of new nano-based platforms for prevention/treatment of life-threatening conditions such as cardiomyopathy, cancer, and neurodegenerative diseases. Aside from nanomedicine and regenerative medicine, Dr. Mahmoudi is also very active in social sciences and specifically in drawing the attention of the scientific community in the rising issue of academic bullying. In addition, he is also working on identifying the reasons behind the enormous disparity between the numbers of major prize winners between the sexes (which currently stands at more than an order of magnitude in favor of male nominees) and seek to draw the attention of award agencies, researchers, entrepreneurs, and media to reexamine the historical imbalances between the sexes in winning major scientific awards. He is among 2018 highly cited researchers in 2018 as reported by Clarivate Analytics.
Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA